Cargando…
Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges
Gastrointestinal cancer (GIC) is the most common cancer with a poor prognosis. Currently, surgery is the main treatment for GIC. However, the high rate of postoperative recurrence leads to a low five-year survival rate. In recent years, immunotherapy has received much attention. As the only immunoth...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611702/ https://www.ncbi.nlm.nih.gov/pubmed/36312831 http://dx.doi.org/10.3748/wjg.v28.i37.5403 |